BRCA Gene Mutations and Hypermethylation – The Flavonoid Potential
BRCA1/2 gene mutations, not included in direct-to-consumer genetic testing, are associated with higher rates of ovarian cancer (17-44%) and breast cancer (69-72%). A new study argues that routine testing for these gene vulnerabilities could prevent up to an estimated 2,666 cases of breast cancer per million women, and up to 449 ovarian cancer cases per…
